microRNA information: hsa-miR-151a-3p

SectionIDlink
Mature name: hsa-miR-151a-3pmiRbase
Accession: MIMAT0000757miRbase
Precursor name: hsa-mir-151a miRbase
Precursor accession: MI0000809miRbase
Symbol: NAHGNC
RefSeq ID: NAGenBank
Sequence: CUAGACUGAAGCUCCUUGAGG


Reported expression in cancers: hsa-miR-151a-3p

miRNAcancerregulationreportingPUBMEDmethod
hsa-miR-151a-3p

prostate cancerupregulation"In this study we investigated whether genistein co ......"22928040


Reported cancer pathway affected by hsa-miR-151a-3p

miRNAcancerpathwayreportingPUBMEDfunctional study


Reported cancer prognosis affected by hsa-miR-151a-3p

miRNAcancerprognosisreportingPUBMEDfunctional study
hsa-miR-151a-3p

breast cancermetastasis"The clinico pathologic role of microRNAs miR 9 and ......"22489664
hsa-miR-151a-3p

gastric cancerprogression"This study identified an intronic microRNA-151 miR ......"27191259Colony formation
hsa-miR-151a-3p

kidney renal cell cancermetastasis; malignant trasformation"To obtain accurate results in miRNA expression cha ......"21741950
hsa-miR-151a-3p

liver cancermetastasis; motility"MiR-151 is aberrantly overexpressed in HCC cells a ......"25023326
hsa-miR-151a-3p

pancreatic cancermetastasis; drug resistance"We report a case of notably increased plasma level ......"23205084
hsa-miR-151a-3p

prostate cancermetastasis; progression; cell migration; poor survival"However the effects of genistein on the regulation ......"22928040Luciferase


Reported gene related to hsa-miR-151a-3p

miRNAcancergenereportingPUBMED
hsa-miR-151a-3p

gastric cancerNOTCH1"This study identified an intronic microRNA-151 miR ......"27191259
hsa-miR-151a-3p

gastric cancerPTK2"Activation of Notch1 pathway enhanced expressions ......"27191259
hsa-miR-151a-3p

breast cancerSMARCA5"miR 151 5p targeting chromatin remodeler SMARCA5 a ......"27385001


Expression profile in cancer corhorts:



Putative target regulations

miRNAGeneCancerInteractionCorrelation beta
hsa-miR-151a-3p
NTRK3
12 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; PRAD; SARC; STAD; UCEC
miRNAWalker2 validate; miRTarBase
TCGA BLCA -0.736; TCGA CESC -0.588; TCGA COAD -1.095; TCGA ESCA -1.565; TCGA KIRC -0.685; TCGA KIRP -0.504; TCGA LUAD -0.489; TCGA LUSC -0.7; TCGA PRAD -0.495; TCGA SARC -0.841; TCGA STAD -1.423; TCGA UCEC -0.652
hsa-miR-151a-3p
MRVI1
13 cancers: BLCA; BRCA; CESC; COAD; ESCA; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BLCA -0.788; TCGA BRCA -0.27; TCGA CESC -0.35; TCGA COAD -0.925; TCGA ESCA -1.006; TCGA LIHC -0.19; TCGA LUAD -0.244; TCGA LUSC -0.451; TCGA PAAD -0.677; TCGA PRAD -0.497; TCGA SARC -1.836; TCGA STAD -1.245; TCGA UCEC -0.817
hsa-miR-151a-3p
SERPINA1
9 cancers: BLCA; BRCA; CESC; KIRP; LUAD; LUSC; PRAD; THCA; UCEC
MirTarget
TCGA BLCA -0.919; TCGA BRCA -0.343; TCGA CESC -0.309; TCGA KIRP -0.798; TCGA LUAD -0.297; TCGA LUSC -0.587; TCGA PRAD -0.571; TCGA THCA -0.868; TCGA UCEC -0.337
hsa-miR-151a-3p
GREM1
10 cancers: BLCA; COAD; ESCA; KIRC; LIHC; LUSC; SARC; THCA; STAD; UCEC
MirTarget
TCGA BLCA -1.582; TCGA COAD -1.32; TCGA ESCA -1.235; TCGA KIRC -2.117; TCGA LIHC -0.526; TCGA LUSC -0.361; TCGA SARC -1.317; TCGA THCA -0.874; TCGA STAD -1.098; TCGA UCEC -0.388
hsa-miR-151a-3p
MGLL
12 cancers: BLCA; BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.582; TCGA BRCA -0.277; TCGA CESC -0.345; TCGA HNSC -0.159; TCGA KIRP -0.369; TCGA LIHC -0.486; TCGA LUAD -0.134; TCGA LUSC -0.405; TCGA PRAD -0.195; TCGA SARC -0.304; TCGA STAD -0.436; TCGA UCEC -0.339
hsa-miR-151a-3p
TP53INP2
12 cancers: BLCA; BRCA; COAD; ESCA; HNSC; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.183; TCGA BRCA -0.175; TCGA COAD -0.301; TCGA ESCA -0.23; TCGA HNSC -0.128; TCGA LIHC -0.334; TCGA LUAD -0.121; TCGA PAAD -0.24; TCGA PRAD -0.249; TCGA SARC -0.736; TCGA STAD -0.514; TCGA UCEC -0.192
hsa-miR-151a-3p
CCND2
10 cancers: BLCA; BRCA; CESC; KIRP; LGG; LUAD; OV; PRAD; STAD; UCEC
mirMAP
TCGA BLCA -0.619; TCGA BRCA -0.178; TCGA CESC -0.25; TCGA KIRP -0.352; TCGA LGG -0.124; TCGA LUAD -0.279; TCGA OV -0.385; TCGA PRAD -0.325; TCGA STAD -0.53; TCGA UCEC -0.673
hsa-miR-151a-3p
UNC5C
9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LUSC; PAAD; STAD; UCEC
mirMAP
TCGA BLCA -0.706; TCGA BRCA -0.226; TCGA COAD -0.531; TCGA ESCA -0.416; TCGA KIRC -0.563; TCGA LUSC -0.379; TCGA PAAD -0.544; TCGA STAD -0.263; TCGA UCEC -0.51
hsa-miR-151a-3p
TEAD1
9 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; SARC; STAD; UCEC
mirMAP
TCGA BLCA -0.169; TCGA BRCA -0.105; TCGA COAD -0.16; TCGA ESCA -0.196; TCGA KIRC -0.182; TCGA LIHC -0.132; TCGA SARC -0.295; TCGA STAD -0.411; TCGA UCEC -0.115
hsa-miR-151a-3p
SLC6A17
10 cancers: BLCA; CESC; COAD; ESCA; KIRC; KIRP; LUAD; LUSC; SARC; STAD
mirMAP
TCGA BLCA -0.636; TCGA CESC -0.869; TCGA COAD -0.725; TCGA ESCA -0.967; TCGA KIRC -1.821; TCGA KIRP -0.666; TCGA LUAD -0.312; TCGA LUSC -0.349; TCGA SARC -1.07; TCGA STAD -0.709
hsa-miR-151a-3p
ZFPM2
9 cancers: BLCA; BRCA; COAD; ESCA; LGG; LIHC; PAAD; STAD; UCEC
miRNATAP
TCGA BLCA -1.021; TCGA BRCA -0.233; TCGA COAD -1.033; TCGA ESCA -1.002; TCGA LGG -0.183; TCGA LIHC -0.419; TCGA PAAD -0.736; TCGA STAD -1.031; TCGA UCEC -0.796
hsa-miR-151a-3p
VAMP1
14 cancers: BLCA; BRCA; CESC; COAD; HNSC; KIRP; LIHC; LUAD; LUSC; PAAD; PRAD; SARC; THCA; STAD
miRNATAP
TCGA BLCA -0.211; TCGA BRCA -0.155; TCGA CESC -0.132; TCGA COAD -0.195; TCGA HNSC -0.108; TCGA KIRP -0.414; TCGA LIHC -0.247; TCGA LUAD -0.364; TCGA LUSC -0.437; TCGA PAAD -0.372; TCGA PRAD -0.403; TCGA SARC -0.573; TCGA THCA -0.19; TCGA STAD -0.461
hsa-miR-151a-3p
PLXNA4
12 cancers: BLCA; BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; OV; PAAD; SARC; STAD
miRNATAP
TCGA BLCA -1.127; TCGA BRCA -0.473; TCGA COAD -1.169; TCGA ESCA -1.105; TCGA KIRC -1.467; TCGA LIHC -0.877; TCGA LUAD -0.213; TCGA LUSC -0.427; TCGA OV -0.339; TCGA PAAD -0.806; TCGA SARC -1.484; TCGA STAD -0.907
hsa-miR-151a-3p
ZNF763
11 cancers: BRCA; HNSC; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; UCEC
miRNAWalker2 validate
TCGA BRCA -0.28; TCGA HNSC -0.195; TCGA KIRC -0.494; TCGA KIRP -0.377; TCGA LIHC -0.225; TCGA LUAD -0.112; TCGA LUSC -0.326; TCGA OV -0.228; TCGA PRAD -0.091; TCGA SARC -0.358; TCGA UCEC -0.146
hsa-miR-151a-3p
ARHGAP23
9 cancers: BRCA; COAD; LIHC; LUAD; PAAD; PRAD; SARC; STAD; UCEC
MirTarget
TCGA BRCA -0.193; TCGA COAD -0.444; TCGA LIHC -0.209; TCGA LUAD -0.18; TCGA PAAD -0.346; TCGA PRAD -0.268; TCGA SARC -0.135; TCGA STAD -0.388; TCGA UCEC -0.262
hsa-miR-151a-3p
RBM5
13 cancers: BRCA; CESC; ESCA; HNSC; KIRC; KIRP; LGG; LUAD; LUSC; PRAD; THCA; STAD; UCEC
MirTarget; miRNATAP
TCGA BRCA -0.163; TCGA CESC -0.081; TCGA ESCA -0.183; TCGA HNSC -0.231; TCGA KIRC -0.158; TCGA KIRP -0.268; TCGA LGG -0.111; TCGA LUAD -0.156; TCGA LUSC -0.199; TCGA PRAD -0.106; TCGA THCA -0.081; TCGA STAD -0.082; TCGA UCEC -0.133
hsa-miR-151a-3p
BEX5
10 cancers: BRCA; KIRC; KIRP; LIHC; LUAD; LUSC; OV; PRAD; SARC; STAD
MirTarget
TCGA BRCA -0.364; TCGA KIRC -0.497; TCGA KIRP -0.455; TCGA LIHC -0.263; TCGA LUAD -0.195; TCGA LUSC -0.402; TCGA OV -0.566; TCGA PRAD -0.507; TCGA SARC -0.932; TCGA STAD -0.625
hsa-miR-151a-3p
MAFK
10 cancers: BRCA; CESC; HNSC; KIRP; LIHC; LUAD; LUSC; PRAD; SARC; UCEC
mirMAP
TCGA BRCA -0.179; TCGA CESC -0.16; TCGA HNSC -0.08; TCGA KIRP -0.381; TCGA LIHC -0.24; TCGA LUAD -0.268; TCGA LUSC -0.254; TCGA PRAD -0.184; TCGA SARC -0.219; TCGA UCEC -0.191
hsa-miR-151a-3p
VGLL3
11 cancers: BRCA; COAD; ESCA; KIRC; LIHC; LUAD; LUSC; PAAD; SARC; STAD; UCEC
mirMAP
TCGA BRCA -0.153; TCGA COAD -0.973; TCGA ESCA -0.909; TCGA KIRC -1.151; TCGA LIHC -0.332; TCGA LUAD -0.218; TCGA LUSC -0.541; TCGA PAAD -0.66; TCGA SARC -1.057; TCGA STAD -0.544; TCGA UCEC -0.791
hsa-miR-151a-3p
CLK1
14 cancers: BRCA; CESC; ESCA; HNSC; KIRP; LGG; LIHC; LUAD; LUSC; PAAD; SARC; THCA; STAD; UCEC
miRNATAP
TCGA BRCA -0.181; TCGA CESC -0.111; TCGA ESCA -0.32; TCGA HNSC -0.319; TCGA KIRP -0.326; TCGA LGG -0.112; TCGA LIHC -0.16; TCGA LUAD -0.175; TCGA LUSC -0.312; TCGA PAAD -0.241; TCGA SARC -0.198; TCGA THCA -0.108; TCGA STAD -0.138; TCGA UCEC -0.186
hsa-miR-151a-3p
LUC7L
9 cancers: CESC; HNSC; KIRP; LGG; LUAD; LUSC; PAAD; PRAD; THCA
MirTarget
TCGA CESC -0.129; TCGA HNSC -0.373; TCGA KIRP -0.388; TCGA LGG -0.233; TCGA LUAD -0.236; TCGA LUSC -0.217; TCGA PAAD -0.332; TCGA PRAD -0.328; TCGA THCA -0.261
hsa-miR-151a-3p
MDM4
9 cancers: CESC; KIRP; LGG; LUAD; LUSC; PAAD; SARC; THCA; UCEC
mirMAP
TCGA CESC -0.155; TCGA KIRP -0.24; TCGA LGG -0.096; TCGA LUAD -0.102; TCGA LUSC -0.106; TCGA PAAD -0.202; TCGA SARC -0.162; TCGA THCA -0.089; TCGA UCEC -0.092




Enriched cancer pathways of putative targets